Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Statement of Cash Flows [Abstract]    
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 4,102 $ 3,735
INVESTING ACTIVITIES    
Acquisition of business   (200)
Purchase of medical equipment and property (2,829) (6,997)
Proceeds from sale of medical equipment and property 3,518 2,511
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 689 (4,686)
FINANCING ACTIVITIES    
Principal payments on revolving credit facility, term loans and capital lease obligations (35,769) (44,197)
Cash proceeds from revolving credit facility 28,317 45,327
Debt issuance costs (38)  
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (27) (50)
Cash proceeds from stock plans 131 125
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (7,386) 1,205
Net change in cash and cash equivalents (2,595) 254
Cash and cash equivalents, beginning of period 3,398 818
Cash and cash equivalents, end of period $ 803 $ 1,072